Evidence map›Paper›PMID 42693923›Full record

ArticleGlobal health action2026

Medication access barriers and perceived health consequences in post-war Syria: a cross-sectional study in Homs.

Rawan Al-Deeb, Ahmad Bishr Nasra, Mohammad Alaa Aldakak, Bayan Muhrat, Shahd Almansour, Ibrahim Auf, Hussein Almohammad, Fater Naimah, Ahmad Hajjo, Nawal Al-Sebai and 1 more

Abstract read
In one paragraph

Article in Global health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rawan Al-DeebFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0002-9028-1151
Ahmad Bishr NasraFaculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.ORCID 0009-0002-8243-9385
Mohammad Alaa AldakakFaculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.ORCID 0009-0003-9600-6326
Bayan MuhratFaculty of Pharmacy, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0004-5340-7397
Shahd AlmansourFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0007-2524-5230
Ibrahim AufFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0006-9790-3717
Hussein AlmohammadFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0006-4904-8728
Fater NaimahFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.
Ahmad HajjoFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0004-1779-4430
Nawal Al-SebaiFaculty of Medicine, Homs University, Homs, Syrian Arab Republic.ORCID 0009-0005-7936-0395
Mohammad KesheDepartment of Chemistry, Faculty of Science, Homs University, Homs, Syrian Arab Republic.ORCID 0000-0003-1471-7646

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundArmed conflict can disrupt medication access through damaged infrastructure, supply shortages, service disruption, transport barriers, and financial hardship. Community-level evidence remains limited in post-war Syria.

objectiveTo assess medication accessibility, perceived barriers and consequences, and factors independently associated with greater barriers among residents of Homs.

methodsA cross-sectional study using convenience sampling included 1,042 participants in Homs between 29 March and 22 April 2026. Data were collected using an adapted, Arabic-translated, pilot-tested questionnaire. A seven-item medication access barrier score was calculated (range, 7-35). Descriptive analyses, nonparametric bivariate tests, and multivariable linear regression with robust standard errors were performed.

resultsMedian age was 26 years (IQR, 22-42), and 62.0% were female. Self-reported poor economic status increased from 10.8% before the war to 30.3% during the war, and only 10.9% reported easy medication access during the war. The median barrier score was 22 (IQR, 20-26). High medication prices were the most frequently endorsed barrier (69.7%). Perceived consequences included health deterioration due to inability to access medications (68.5%) and deaths attributed to medication shortages (53.2%). In adjusted analysis, self-reported poor wartime economic status, student status, and greater distance to the nearest medication provider were associated with higher barrier scores, whereas less than high-school education was associated with lower scores.

conclusionsMedication access problems were commonly reported and were associated with socioeconomic and geographic factors. These findings may inform post-conflict strategies addressing medicine affordability, supply continuity, and access to care.

Indexed as

Armed ConflictsHealth Services AccessibilityAdultCross-Sectional StudiesFemaleHumansMaleSocioeconomic FactorsSurveys and QuestionnairesSyriaYoung Adultconflict-affected populationsEssential medicineshealthcare affordabilityhealth systems recoverypharmaceutical supply chains

Identifiers

PMID42693923
PMCPMC13552326

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.